KKR Real Estate Finance Trust Earnings Calls
| Release date | Apr 22, 2026 |
| EPS estimate | $0.151 |
| EPS actual | -$0.0600 |
| EPS Surprise | -139.76% |
| Revenue estimate | 28.121M |
| Revenue actual | 34.599M |
| Revenue Surprise | 23.04% |
| Release date | Feb 03, 2026 |
| EPS estimate | $0.130 |
| EPS actual | $0.220 |
| EPS Surprise | 69.23% |
| Revenue estimate | 29.894M |
| Revenue actual | 32.64M |
| Revenue Surprise | 9.19% |
| Release date | Oct 21, 2025 |
| EPS estimate | $0.0100 |
| EPS actual | -$0.0300 |
| EPS Surprise | -400.00% |
| Revenue estimate | 26.06M |
| Revenue actual | 25.334M |
| Revenue Surprise | -2.79% |
| Release date | Jul 22, 2025 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.530 |
| EPS Surprise | -231.25% |
| Revenue estimate | 32.28M |
| Revenue actual | 118.55M |
| Revenue Surprise | 267.26% |
Last 4 Quarters for KKR Real Estate Finance Trust
Below you can see how KREF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 22, 2025 |
| Price on release | $9.05 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.530 |
| EPS surprise | -231.25% |
| Date | Price |
|---|---|
| Jul 16, 2025 | $9.10 |
| Jul 17, 2025 | $9.00 |
| Jul 18, 2025 | $8.88 |
| Jul 21, 2025 | $8.88 |
| Jul 22, 2025 | $9.05 |
| Jul 23, 2025 | $9.07 |
| Jul 24, 2025 | $9.18 |
| Jul 25, 2025 | $9.23 |
| Jul 28, 2025 | $9.18 |
| 4 days before | -0.549% |
| 4 days after | 1.44% |
| On release day | 0.221% |
| Change in period | 0.88% |
| Release date | Oct 21, 2025 |
| Price on release | $8.68 |
| EPS estimate | $0.0100 |
| EPS actual | -$0.0300 |
| EPS surprise | -400.00% |
| Date | Price |
|---|---|
| Oct 15, 2025 | $8.68 |
| Oct 16, 2025 | $8.51 |
| Oct 17, 2025 | $8.63 |
| Oct 20, 2025 | $8.55 |
| Oct 21, 2025 | $8.68 |
| Oct 22, 2025 | $8.63 |
| Oct 23, 2025 | $8.66 |
| Oct 24, 2025 | $8.71 |
| Oct 27, 2025 | $8.74 |
| 4 days before | 0% |
| 4 days after | 0.691% |
| On release day | -0.576% |
| Change in period | 0.691% |
| Release date | Feb 03, 2026 |
| Price on release | $8.18 |
| EPS estimate | $0.130 |
| EPS actual | $0.220 |
| EPS surprise | 69.23% |
| Date | Price |
|---|---|
| Jan 28, 2026 | $8.40 |
| Jan 29, 2026 | $8.44 |
| Jan 30, 2026 | $8.28 |
| Feb 02, 2026 | $8.31 |
| Feb 03, 2026 | $8.18 |
| Feb 04, 2026 | $7.88 |
| Feb 05, 2026 | $7.27 |
| Feb 06, 2026 | $7.32 |
| Feb 09, 2026 | $7.22 |
| 4 days before | -2.62% |
| 4 days after | -11.74% |
| On release day | -3.67% |
| Change in period | -14.05% |
| Release date | Apr 22, 2026 |
| Price on release | $6.70 |
| EPS estimate | $0.151 |
| EPS actual | -$0.0600 |
| EPS surprise | -139.76% |
| Date | Price |
|---|---|
| Apr 16, 2026 | $6.62 |
| Apr 17, 2026 | $6.69 |
| Apr 20, 2026 | $6.83 |
| Apr 21, 2026 | $6.69 |
| Apr 22, 2026 | $6.70 |
| Apr 23, 2026 | $6.09 |
| Apr 24, 2026 | $6.01 |
| Apr 27, 2026 | $5.88 |
| Apr 28, 2026 | $6.24 |
| 4 days before | 1.21% |
| 4 days after | -6.87% |
| On release day | -9.18% |
| Change in period | -5.74% |
KKR Real Estate Finance Trust Earnings Call Transcript Summary of Q1 2026
KKR Real Estate Finance Trust (KREF) reported a GAAP net loss of $62 million (negative $0.96/sh) for Q1 2026, book value was $11.87/sh, distributable loss was $4 million (negative $0.06/sh), and distributable earnings before realized losses were $13 million ($0.20/sh). Management calls 2026 a transition year focused on (1) aggressively resolving watch-list assets and legacy office exposure (target: reduce legacy office from 21% to under 10%), and (2) positioning portions of the REO portfolio for liquidity and redeployment. The company has significant liquidity (reported $653 million at quarter end, including $135 million cash and $500 million revolver capacity) and expects >$2 billion of loan repayments in 2026, which management estimates will translate into roughly $500 million of investable capital. To prioritize capital allocation and drive book-value accretion, the board reduced the quarterly dividend to $0.10 (from $0.25) and authorized a $75 million share repurchase program. Management expects distributable earnings to trough in H2 2026 into H1 2027 as the portfolio is repositioned, but sees a path back to earnings growth and book-value stability as newer-vintage loans (2024–2026 vintages) are expected to represent ~50% of the portfolio by year-end. Watch-list actions this quarter included material CECL provisions (+$74M) raising the allowance to $260M; one Boston life-science loan is expected to transition to REO in Q2 with an anticipated realized loss of ~ $37M (already reserved). The company emphasizes optionality: continuing originations, REO monetizations (near/medium/long-term buckets highlighted with Mountain View as a key monetization asset), and share buybacks to create accretion given current trading levels relative to book value. Balance sheet/financing highlights: total financing availability of $7.2B (including $2.6B undrawn), debt-to-equity ~2.2x, total leverage ~4x, no near-term corporate debt maturities until 2030, and no final facility maturities until 2027. Management expects to resolve all current watch-list loans by year-end and to continue originating new, higher-quality loans to improve earnings power over time.
Sign In
Buy KREF